A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

BATF2 is a new type of tumor suppressor that can be epigenetically silenced by high levels of glutamine in the tumor microenvironment Glutamine silences BATF2 and leads to a weakened immune response ...

The gut microbiome has been shown to influence tumor growth and contribute to therapeutic resistance. Scientists have ...

Phase II postoperative adjuvant radiotherapy and erlotinib in patients with stage III cutaneous squamous cell carcinoma. Background: Soft tissue sarcomas account for less than 1% of all head and neck ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical ...

Soft-tissue sarcomas are tumors that can happen in many different tissues in the body. Most soft-tissue sarcomas begin in the arms, legs, or the body wall. People usually first notice a painless lump, ...